Aanika Biosciences Launches Insurance Vehicle “Aanika Re” with Initial Backing From Adit Ventures

BROOKLYN, N.Y.–(BUSINESS WIRE)–Adit Ventures, a global venture capital firm with over $400 million in AUM, has agreed to seed Aanika Re, a Bermuda-based insurance vehicle wholly owned by Aanika Biosciences, inc. Aanika Re’s mandate is to leverage the microbial tagging technology developed by Aanika Biosciences, as well as a broader swath of biological innovations, to … [Read more…]

Rapid Medical Gains FDA Clearance for the Smallest & Only Adjustable Thrombectomy Device

TIGERTRIEVER™13 is designed to reduce vessel tension during ischemic stroke treatment YOKNEAM, Israel & TORONTO–(BUSINESS WIRE)–#COMANECI—Rapid Medical, a leading developer of advanced neurovascular devices, announces FDA 510(k) clearance for TIGERTRIEVER™13 for large vessel occlusions at the 2022 Society of NeuroInterventional Surgery’s (SNIS) 19th Annual Meeting in Toronto. TIGERTRIEVER 13 is the smallest revascularization device in … [Read more…]

Taro to Release First Quarter Results on July 27, 2022

HAWTHORNE, N.Y.–(BUSINESS WIRE)–Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the first quarter ended June 30, 2022, after the close of market on Wednesday, July 27, 2022. The release will be accessible on Taro’s website at www.taro.com. About Taro Taro Pharmaceutical Industries Ltd. is a multinational, … [Read more…]

Aurinia Pharmaceuticals Notification Regarding Inter Partes Patent Review

VICTORIA, British Columbia and ROCKVILLE, Md.–(BUSINESS WIRE)–Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (“Aurinia” or the “Company”) today received notice regarding the U.S. Patent Office (USPTO) Patent Trial and Appeal Board (PTAB) decision to institute trial on the Inter Partes review (“IPR”) filed by Sun Pharmaceuticals, directed at U.S. Patent No. 10,286,036. This patent is related to … [Read more…]

Asia Pacific Non-invasive Aesthetic Treatment Market Report 2022: Key Players Allergan, Merz Pharma, Johnson & Johnson and Others Driving 14.4% Annual Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Asia Pacific Non-invasive Aesthetic Treatment Market Size, Share & Industry Trends Analysis Report By End-Use (MedSpa, Hospital/Surgery Center, Traditional Spa, and HCP Owned Clinic), By Procedure, By Country and Growth Forecast, 2021-2027” report has been added to ResearchAndMarkets.com’s offering. The Asia Pacific Non-invasive Aesthetic Treatment Market is expected to witness market growth of … [Read more…]

Parentis Health Acquires Quality Life Homes to Expand Its Verona Court Residential Care Division

ORANGE COUNTY, Calif. & LAGUNA NIGUEL, Calif.–(BUSINESS WIRE)–#California—Parentis Health, a healthcare company focusing on senior care, has acquired Quality Life Homes licensed residential home care facilities for elderly and memory-impaired individuals. The deal closed July 1; terms are not disclosed. The Quality Life facilities, all located in Laguna Niguel, will transition to the Verona Court … [Read more…]

Merck Announces Fourth-Quarter 2022 Dividend

RAHWAY, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the Board of Directors has declared a quarterly dividend of $0.69 per share of the company’s common stock for the fourth quarter of 2022. Payment will be made on Oct. 7, 2022, to shareholders of record at … [Read more…]

Europe Hearing Care Devices Market Report 2022-2028: Technological Advancements in Smart Hearing Aids Presents Opportunity for Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Europe Hearing Care Devices Market Size, Share & Industry Trends Analysis Report By Product, By End User (Home-use, Ambulatory Surgical Centers (ASCs), and Hospitals & Clinics), By Country and Growth Forecast, 2022-2028” report has been added to ResearchAndMarkets.com’s offering. The Europe Hearing Care Devices Market is expected to witness market growth of 4.6% … [Read more…]

First German EVBA Procedure is Performed with New Heart Failure Therapy Approach

Latest Data and Live Broadcast Show Promise of Vascular Dynamics’ MobiusHD Device IRVINE, Calif.–(BUSINESS WIRE)–Vascular Dynamics, Inc. (VDI), a privately held medical device company focused on developing game-changing endovascular device-based solutions for patients suffering from heart failure, announced that the endovascular baroreflex amplification (EVBA) procedure using its MobiusHD device to treat patients with heart failure … [Read more…]